Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats-Reference-Cited by-同舟云学术

Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats

Published:2015-04-26 Issue:12 Volume:6 Page:9718-9727
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lesovaya Ekaterina A.¹,Kirsanov Kirill I.¹,Antoshina Elena E.¹,Trukhanova Lubov S.¹,Gorkova Tatiana G.¹,Shipaeva Elena V.²,Salimov Ramiz M.²,Belitsky Gennady A.¹,Blagosklonny Mikhail V.³,Yakubovskaya Marianna G.¹,Chernova Olga B.⁴

Affiliation:

1. Department of Chemical Carcinogenesis, Blokhin Cancer Research Center, Moscow, Russia

2. Tartis-Aging LLC, Moscow, Russia

3. Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA

4. Everon Biosciences, Inc., Buffalo, NY, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress on the Mechanism of Chinese Herbal Compounds Treating Benign Prostatic Hyperplasia by Regulating Inflammatory Response;Integrative Medicine in Nephrology and Andrology;2024-08-21

2. The role of autophagy in prostate cancer and prostatic diseases: a new therapeutic strategy;Prostate Cancer and Prostatic Diseases;2024-01-31

3. Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway;Food Science and Human Wellness;2023-11

4. The Effects of Cordycepin on Benign Prostatic Hyperplasia through Autophagy Activation in BPH-1 Cell Line;Cell and Tissue Biology;2023-08

5. Perturbed autophagy intervenes systemic lupus erythematosus by active ingredients of traditional Chinese medicine;Frontiers in Pharmacology;2023-01-17